Sarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 cases Aims: To analyse the clinical and pathological features with long-term follow-up of a series of 12 cases of sarcomatoid carcinoma of the breast. Methods and results: The cases were selected from the surgical ®les of the Department of Pathology, University of Edinburgh, between 1977 and 1988 . The following clinical parameters were recorded: the age of the patients, size of tumour, presence or absence of lymph node or distant metastases, and patient survival. Pathological assessment included: the type of epithelial and mesenchymal components, the proportion of monophasic to biphasic tumours and the presence of adjacent in-situ carcinoma/atypical epithelial proliferation. The mean age of the patients was 61 years with a median of 64 and range 46±82 years. The mean size of the tumour was 52 mm (range 22±100 mm). None of the patients had distant metastasis at presentation and only one case had local lymph node metastasis which had a carcinomatous appearance. Five women were still alive after a minimum 12-year follow-up period. Four patients died of their disease (three with lung metastasis only and one with lung and bone metastases), one died of carcinoma of the cervix and two patients were lost to follow-up. Pathologically, four cases (33.3%) had no or almost undetectable epithelial structures by light microscopy, i.e.`monophasic sarcomatoid carcinoma'. The remaining cases revealed varying proportions of both epithelial and mesenchymal elements, i.e.`biphasic sarcomatoid carcinoma'. Of the epithelial component, six (50%) tumours had predominantly carcinoma of no special type, one lobular and one tubular carcinoma. The mesenchymal component was ®bromatosis/nodular fasciitis-like, malignant ®brous histiocytoma-like (MFH), osteosarcoma-like and ®brosarcoma-like in ®ve (42%), four (33%), two (17%) and one (8%) tumours, respectively. In 3/4 monophasic tumours, the mesenchymal component was of a low-grade ®bromatosis/nodular fasciitis type. In 6/12 (50%) of the cases there was associated in-situ atypical epithelial proliferation (®ve ductal carcinoma in situ (DCIS) and one atypical ductal hyperplasia). Conclusions: From this small series it appears that sarcomatoid carcinoma is an uncommon tumour, which is large in size and tends to lack local or distant metastasis at presentation. Pathologists should be alert to the presence of the bland monophasic sarcomatoid carcinoma which has a pure mesenchymal appearance on light microscopy, but epithelial components demonstrated by cytokeratin immunohistochemistry. These showed metastases on long-term follow-up, similar to other histological patterns of sarcomatoid carcinoma.
Introduction
Tumours showing both carcinomatous and sarcomatous features are very uncommon and occur in various anatomical sites. 1±9 Their wide range of microscopic appearances have resulted in a variety of names such as`carcinosarcoma', 8±10`c arcinoma with pseudosarcomatous stroma', 11,12`s pindle cell carcinoma' 13±16 and in the female genital tract`malignant mixed mullerian tumour'. 5 In the breast, this tumour is often called`metaplastic carcinoma'. 1, 17, 18 In spite of the differences in terminology in different organ systems, the evidence suggests that these are similar tumours developing through a peculiar phenotypic transformation of carcinoma cells into sarcoma. 16,19±22 This theory is supported by the ®nding of morphological transition' from carcinoma to sarcoma, the detection of epithelial features in sarcomatous cells by electron microscopy or immunohistochemistry, and the predominance of epithelium in the metastases. 1, 16, 19, 20, 22 In the breast, the most popular theory regarding the histogenesis of the sarcomatous component is through transformation of myoepithelial cells. 1,18,23±25 In support of this is the ®nding of a cuff-like proliferation of neoplastic myoepithelial cells around residual breast ducts in some tumours. 1, 25 An alternative theory is that malignant epithelial cells undergo myo®broblastic metaplasia. 26, 27 We prefer the term`sarcomatoid carcinoma' rather than metaplastic carcinoma when referring to these tumours. 1, 19 Classic sarcomatoid carcinoma is a tumour with both epithelial and mesenchymal components, hence the term biphasic sarcomatoid carcinoma. 1 Several reports have described a monophasic variant which appears purely mesenchymal on light microscopy, but which has an epithelial component which can be demonstrated by immunohistochemistry for cytokeratins. 1, 24, 28, 29 The mesenchymal component can vary between a pleomorphic sarcomatous appearance and a bland appearance which may mimic nodular fasciitis, ®bromatosis or a granulation tissue reaction. 28±30 In a series reported by Gobbi et al., monophasic sarcomatoid carcinoma with a ®bromatosis-like appearance has no regional or distant metastasis but a local recurrence rate of 26.7% within a period of 5±72 months follow-up period. 29 In the Department of Pathology, Edinburgh University, we obtained 12 cases of sarcomatoid carcinoma of the breast diagnosed between 1978 and 1988. The aim of this study was to analyse the clinical and pathological features of these tumours, determining the epithelial and mesenchymal components, the percentage of monophasic sarcomatoid carcinoma and the status of the adjacent breast tissue. These parameters were examined in the light of a relatively very long (12±22 years) follow-up period.
Materials and methods
The following parameters were recorded: the age of the patients, size of tumour at presentation, presence or absence of lymph node or distant metastases, treatment modality, and patient survival.
The ®les of the Pathology Department, Edinburgh University, were searched from January 1977 to December 1988 for all cases diagnosed as metaplastic carcinoma or carcinosarcoma of the breast (these terms are the most commonly used codes in the department for such tumours). The reviewed material included breast biopsies and mastectomy specimens with axillary node samples or clearances. These were Bouin or formalin ®xed and stained with haematoxylin and eosin. Only cases that ful®lled the criteria for sarcomatoid carcinoma were selected. These cases were either biphasic or monophasic. The biphasic tumours had both epithelial and mesenchymal components on light microscopy. The monophasic had a purely spindle mesenchymal appearance on light microscopy but had epithelial components demonstrated by immunohistochemistry for low molecular weight cytokeratins (see Figure 1 ).
Assessment included the following: the type of the epithelial and stromal components, the proportion of monophasic cases, the presence of adjacent atypical hyperplasia or DCIS, the presence of cystic change, haemorrhage or necrosis.
Results

C L I N I C A L I N F O R M A T I O N
The mean age of the patients was 61 years with a median of 64 and range 46±82 years (Table 1) . Eight cases were in the left breast and four in the right breast.
The mean size of the tumour was 52 mm (range 22± 100 mm) and all were relatively well circumscribed. One woman had a metastatic carcinoma in the axillary lymph node at presentation. Eleven patients were treated by mastectomy, ®ve of these were combined with axillary node clearance and one patient had wide local excision with axillary node sample.
Five women were still alive 12±22 years after presentation, four died of their disease (three with lung metastases only and one with lung and bone metastases), and one died of carcinoma of the cervix. Two patients were lost to follow-up.
Eight women (66.6%) had biphasic tumours and four (33.3%) had monophasic tumours.
The mesenchymal component in these 12 cases was as follows: ®bromatosis/nodular fasciitis-like (n 5) (Figure 2 ), malignant ®brous histiocytoma-like (n 4) (Figure 3 ), osteo/chondrosarcoma (n 2) (Figure 4) , and ®brosarcoma (n 1). Coexisting DCIS was found in ®ve cases (41%) and atypical ductal hyperplasia in one case (8%). Of the secondary features identi®ed, ®ve cases showed areas of haemorrhage, three focal necrosis and two cystic changes.
In the biphasic group, the epithelial component was as follows: carcinoma of no special type (NST) (n 6), lobular carcinoma (n 1) (Figure 5a ,b) and tubular carcinoma (n 1). Three out of the six cases with carcinoma of NST showed small foci of specialized differentiation: one had squamous, one had both squamous and clear cell and one had apocrine change.
In the monophasic group, 3/4 tumours were of the ®bromatosis/nodular fasciitis pattern and one was osteo/chondrosarcoma-like.
C L I N I C O P A T H O L O G I C A L C O R R E L A T I O N
Eleven women had mastectomies (®ve with axillary lymph node clearances) and one had a wide local excision with axillary node sample.
Four patients died from their disease 1 year, 2 years, 3 years and 7 years following diagnosis (average survival of 3 years and 7 months). The tumour sizes of these four patients averaged 39 mm. Three out of these four women had monophasic tumour (two bland ®bromatosis-like appearance and one osteo/chondrosarcoma-like) and the fourth woman had a biphasic tumour (an NST epithelial component with a ®bro-sarcoma-like mesenchymal element).
Discussion
In this study we have found that the clinical presentation and survival of women with sarcomatoid carcinoma is comparable to previously reported series. 1,17,18,24,26, 1 31 The mean age of women in our series was 61 years (range 46±82 years) and their tumours were relatively large and well circumscribed. It has been previously suggested that the size at initial excision is one of the best predictors of survival. 17 However, in this study the mean tumour size of those who died of their disease was smaller (39 mm) compared with the overall average size (52 mm).
Only one woman had a local lymph node involvement by carcinoma at presentation, while the rest lacked local or distant metastasis. This con®rms previous evidence that suggests that the majority of sarcomatoid carcinomas have not metastasized at presentation despite their large size. 17 Our series includes signi®cantly longer term follow-up than previous reports, with patients monitored between 12 and 22 years after diagnosis. However, the overall survival in our series is consistent with previous reports, with 4/12 (33.3%) dying of their disease. Most published data on metastases of sarcomatoid carcinoma have shown haematogenous rather than lymphatic spread, in keeping with the sarcomatous phenotype. 1, 11, 17, 18, 24, 25, 32, 33 In this series, four patients developed haematogenous metastases (lung and bone) resulting in their death. One of these patients had carcinoma in a lymph node at presentation.
In view of the various names given to this tumour, the literature regarding the epithelial component differs according to the term used. Those reports describing metaplastic carcinoma have identi®ed a signi®cant squamous component. 1, 17, 18 However, those referring to carcinosarcoma have shown a predominant carcinomatous component of NST. 1, 17, 18, 24, 26 In this study the commonest epithelial element was carcinoma of NST. This occurred in six cases (50%) and was associated with smaller foci of squamous, clear cell or apocrine metaplasia. In addition, we identi®ed one case with lobular carcinoma (Figure 5a,b,c) , which to our knowledge has not been described previously. This is important for pathologists, as lobular carcinoma cells are usually uniform and small in size and therefore could easily be obscured by the mesenchymal component.
In-situ ductal carcinoma has been reported in up to 25% of mammary sarcomatoid carcinoma 23 and up to 66% of cases of ordinary invasive breast carcinoma of no special type. 34 In this study 50% of our cases showed DCIS or atypical epithelial proliferation. This further supports the epithelial origin of these tumours.
A recent report has identi®ed a relationship between metaplastic carcinoma of the breast and complex Sarcomatoid breast carcinoma 61 sclerosing lesions/radial scars. 35 However, in the latter study four out of ®ve cases were low-grade adenosquamous carcinomas. In our series none of the cases of sarcomatoid carcinoma was associated with radial scars.
In this report we have identi®ed eight cases (66.6%) of biphasic sarcomatoid carcinoma compared with four cases (33.3%) of monophasic sarcomatoid carcinoma. The percentage of monophasic sarcomatoid carcinoma in this series is comparable to those previously reported. 1, 23, 24, 28, 32 In the largest series of 100 cases of sarcomatoid carcinoma, described by Wargotz et al. only 17 cases were of monophasic sarcomatoid carcinoma. 24 However, in the series reported by Gobbi et al. 29 10 out of 30 cases (33%) of metaplastic breast carcinoma were monophasic.
The diagnosis of sarcomatoid carcinoma should be considered in the differential diagnosis of any biphasic or monophasic sarcomatoid tumour of the breast. 36 The main differential diagnosis of these tumours includes phyllodes tumours and primary breast sarcomas. 36 The problem in the pathological diagnosis of sarcomatoid carcinomas lies with the monophasic variant. Diagnosis can be established with the use immunohistochemistry for low molecular weight keratins, which can identify epithelial islands with a deceptive spindle morphology. Epithelial membrane antigen is usually con®ned to clearly recognizable epithelial structures. Vimentin is expressed in both the epithelial and sarcoma-like components. 19, 29 The question remains whether the histological patterns of sarcomatoid carcinoma have an in¯uence on patients' survival. The differences in survival among the various subgroups of sarcomatoid carcinoma are said to be minor. 11, 17, 24 From our small series, patient survival appeared to be independent of pattern. However, it should be noted that our two cases of monophasic sarcomatoid carcinoma with a bland ®bromatosis-like appearance behaved aggressively, resulting in the patients' death 5 and 7 years after diagnosis. This is unlike those that have been reported by Gobbi et al., 29 where metaplastic carcinoma of the breast with a ®bromatosis-like picture has demonstrated no regional or distant metastasis 5±88 months following diagnosis. It may well be that tumour metastasis occurs later in the natural history of these particular tumours.
In summary, from this small series it appears that sarcomatoid carcinoma is a rare pattern of breast cancer (12 cases in a 10-year period). Although the lesion is relatively large in size, it tends to lack local or distant metastasis at presentation. The epithelial component of sarcomatoid carcinoma can include lobular carcinoma. Lastly, the bland monophasic sarcomatoid carcinoma with the ®bromatosis/nodular fasciitis-like appearance metastasizes similar to other sarcomatoid carcinomas.
